Alert

Recommended Alerts

Sign Up For Alerts

Patent/PTAB Litigation Changes in Senator Leahy’s “Restoring the America Invents Act”

In 2011, Congress passed the Leahy-Smith America Invents Act (the “AIA”), implementing the most significant reformation to the U.S. patent system in over fifty years. Among the many changes of the AIA was the creation of the Patent Trial and Appeal Board (the “PTAB”). The PTAB serves as the judicial body of the United States Patent and Trademark Office (the “USPTO”) that adjudicates AIA trial proceedings of challenged patents. A decade later, one of the AIA’s namesakes, Senator Patrick Leahy – VT (D), is seeking to recalibrate practices that have evolved due to recent court decisions and PTAB directives that he sees as contrary to goals of the original AIA legislation. As such, Senator Leahy has introduced a new bill entitled the “Restoring the America Invents Act.”

Read More

Woglom to address London pharmaceutical patent conference


Time to Read: 1 minutes Practices: Intellectual Property

Eric C. Woglom, a partner in the Fish & Neave IP Group of Ropes & Gray, will discuss recent legislative and judicial developments affecting the U.S. pharmaceutical industry, including the status of proposed patent law reform measures, at the fifth annual Pharmaceutical Patent Life Cycles Conference in London on January 19-20, 2006.

Presented by C5, the conference provides authoritative information on strategies and developments in the field of pharmaceutical patents to a large audience of in-house and patent counsel, attorneys, patent agents and directors and managers of IP from pharmaceutical companies worldwide.

Cookie Settings